1. Acknowledgment

   Acknowledgments 17 August 2012 Pages: 353 - 354

2. Dronedarone

   • Alena Shantsila
   • Gregory Y. H. Lip

   Editorial 17 August 2012 Pages: 355 - 356

3. Pioglitazone is a Valid Alternative to Rosiglitazone

   • Giuseppe Derosa

   Current Opinion 17 August 2012 Pages: 357 - 362

4. Defining the Role of Lipoprotein Apheresis in the Management of Familial Hypercholesterolemia

   • Wai Ping Lee
   • Borunendra N. Datta
   • Julian Halcox

   Review Article 17 August 2012 Pages: 363 - 370

   

5. Apolipoprotein E Mimetics and Cholesterol-Lowering Properties

   • Oleg F. Sharifov
   • Gaurav Nayyar
   • Himanshu Gupta

   Review Article 17 August 2012 Pages: 371 - 381

   

6. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

   • Stacy D. Fisher
   • Brinder S. Kanda
   • Steven E. Lipshultz

   Review Article 17 August 2012 Pages: 383 - 394

   

7. Dronedarone and the Incidence of Stroke in Patients with Paroxysmal or Persistent Atrial Fibrillation

   • Nikolaos Dagres
   • Christos Varounis
   • Maria Anastasiou-Nana

   Original Research Article 17 August 2012 Pages: 395 - 400

   

8. Comparing Antihypertensive Effect and Plasma Ciclosporin Concentration between Amlodipine and Valsartan Regimens in Hypertensive Renal Transplant Patients Receiving Ciclosporin Therapy

   • Jingjing Cai
   • Zhijun Huang
   • Hong Yuan

   Original Research Article 17 August 2012 Pages: 401 - 409

   

9. HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects

   • Shigemasa Tani
   • Ken Nagao
   • Atsushi Hirayama

   Short Communication 17 August 2012 Pages: 411 - 417

   

10. The Authors’ Reply

    • Alex F. Manini
    • Lewis S. Nelson
    • Robert S. Hoffman

    Correspondence 17 August 2012 Pages: 419 - 420